Andrew Bottomley

Psychologist and Researcher, Ph.D, Expert in Clinical Trials and PRO, Consultant, Oncology, Outcomes Researcher

[Xing Wei, MD, MSc @SurgeonXingWEI]

Our latest research has been published in JCO once again! @JCO_ASCO @ASCO This multicenter, randomized controlled trial demonstrates the long-term benefits of electronic patient-reported outcomes (ePRO) in postoperative management of lung cancer.
https://t.co/7lnO0FIjj6

[Andrew Bottomley @andrewbottom0]

🌟 Exciting Announcement! 🌟

We are thrilled to share some big news with our community!

🤝 DeltaQuest Foundation, Inc. USA and Bottomley Consulting Group, Belgium Join Forces to Advance Patient-Centric Research Initiatives 🤝

[Andrew Bottomley @andrewbottom0]

I am pleased to participate in @proteuspros and to share they are collaborating with @pfizer Global Medical Grants on an RFP for projects up to $100k investigating the value of using patient-reported outcomes in US cancer clinical practice. Details here: https://t.co/d2QFO0d2iq.

[Andrew Bottomley @andrewbottom0]

Celebrating strides against financial discrimination for cancer survivors at the EU Conference in Brussels. 11 countries have embraced change, and we aim for all 27 to join in. Ministers and the European Commission express strong support, paving the way for an enhanced QOL#qol

[Andrew Bottomley @andrewbottom0]

@MyelomaEurope It's a commendable initiative by MPE. Kudos to Vincent! I find myself increasingly impressed by the excellent work efforts of MPE. Please continue the outstanding efforts to ensure the patients' voices are heard loud and clear.

[Craig Horbinski @CraigHorbinski]

⁦@KatyPetersMDPhD⁩ with a stellar presentation about vorasidenib and quality of life in IDHmut glioma patients. #sno2023

[Andrew Bottomley @andrewbottom0]

I am so delighted to announce our partnership with 5P Health Care Solutions Inc. Read our message ⤵️

Keywords
#PROMS #PREMS #HR_QOL #HEOR #RWD

[Andrew Bottomley @andrewbottom0]

Had an inspiring day at the Frankfurt conference discussing next-gen immuno-therapy and Quality of Life. Exciting to bridge lessons from early immunotherapy studies to boost trials of next-gen treatments! 🚀 #ImmunoTherapy #QualityOfLife #MedicalConference
#proteus

[IBTA @theIBTA]

.@KathyOliverIBTA opens the IBTA 2023 World Summit of Brain Tumour Patient Advocates in Vienna #IBTASummit2023

[The PROTEUS Consortium @proteuspros]

#ASCO23 attendees! Sunday, June 4 at 11:30 am CT Drs. Claire Snyder, Gita Thanarajasingam, & Debra Patt will present "Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity." Hope to see you there! @ASCO @GitaThanaMD @dapattmd https://t.co/K8UOI7jrFN

[Andrew Bottomley @andrewbottom0]

New findings from Ivan Caramanna's retrospective analysis of 500+ high grade glioma patients: impaired patients with recurrent HGG are more aware of their neurocognitive limitations. #patientoutcomes #oncology https://t.co/jlJosegP7D.

[Andrew Bottomley @andrewbottom0]

Thanks for sharing this nice paper from Morton, Mogens and Hugo! Good work from our QLG !

[COA Katja (Outcomes Specialist) @CoaKatja]

https://t.co/ZmpFwjlOAV

Nice progress for cancer patients AND caregivers - reduced burden without loss of power.

[Andrew Bottomley @andrewbottom0]

Hey everyone, just wanted to let you know that my Twitter account was hacked. I've fixed the issue and reported it to Twitter. Sorry for any inconvenience and thanks for understanding!" #TwitterHack #AccountSecurity

[Andrew Bottomley @andrewbottom0]

@u1rokikawa Dear Yuichiro,

Congratulations to my colleagues and friends at the JCOG QOL/PRO committee for promoting high standards for QOL clinical research in Japan. Its great to see this develop and move forward. 

Andrew

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

In the latest issue of @TheLancetOncol, Policy Review by C Piccinin et al addresses the need for more flexible ways to capture the patient voice, while preserving the rigour of standard (static) questionnaires.

Read more 👇
https://t.co/AZoVq1sNye

#GivingVoice2Patients #PROMs

[Andrew Bottomley @andrewbottom0]

EUonQol! What is it? It’s a brand new project, costing 10 million euros and funded by the European commission. Today is the kick off meeting in Milan! This work aims to create a new QOL barometer to annually evaluate the QOL of European cancer patients.

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

ESMO developed a checklist to assess robustness of #QualityofLife research to use for ESMO-MCBS grading:"This shows the true value academic societies like @EORTC & @myESMO place on the views of the patient"@andrewbottom0 highlights in ESMO press release👇

https://t.co/X8d6ybiuOZ

[Andrew Bottomley @andrewbottom0]

It was wonderful to work with the super ESMO team on updating these important guidelines and strengthening to QOL elements. Thanks for allowing us at EORTC to help out!

[Annals of Oncology @Annals_Oncology]

After analysing guidelines for QoL research & testing on selected clinical trials, the @myESMO -MCBS Working Group and Extended Working Group has developed a 4-item checklist to be applied when certain prerequisites are met 👇
https://t.co/X9tcWYpW9V
@OostingSjoukje @ChernyNathan

[Andrew Bottomley @andrewbottom0]

Take a look at this short little video of our history in the QLG. Happy Christmas and New Year to all…

[EORTC @EORTC]

What a year! @eortc 60th and @EORTC_QLG 40th. 👍👏👏👏

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

Save the date! Our 6th @EORTC #QualityofLife in Cancer Clinical Trials Conference will be held on 25&26 September 2023 in Barcelona & will address “Clinical trials: from conception to publication”.

More info available soon: https://t.co/T6ahibYiCP

#QoL2023 #GivingVoice2Patients